Cargando…
Present and Future Research on Anal Squamous Cell Carcinoma
SIMPLE SUMMARY: This is an exciting moment in clinical research in the squamous cell carcinoma of the anus (SCCA). Historical barriers regarding this disease are vanishing thanks to the creation of research networks in this rare pathology, gained knowledge in tumor biology and its environment in thi...
Autores principales: | Spehner, Laurie, Boustani, Jihane, Cabel, Luc, Doyen, Jérôme, Vienot, Angélique, Borg, Christophe, Kim, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345786/ https://www.ncbi.nlm.nih.gov/pubmed/34359795 http://dx.doi.org/10.3390/cancers13153895 |
Ejemplares similares
-
Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma
por: Grave, Athénaïs, et al.
Publicado: (2022) -
Editorial: New understandings and research in anal squamous cell carcinoma
por: Kim, Stefano, et al.
Publicado: (2023) -
Anti-Telomerase CD4(+) Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials
por: Spehner, Laurie, et al.
Publicado: (2020) -
Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma
por: Hervé, Laure, et al.
Publicado: (2022) -
Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial
por: Debernardi, Alice, et al.
Publicado: (2022)